Evidence map›Paper›PMID 16014956›Full record

ArticleJournal of virology2005

Soluble mimetics of human immunodeficiency virus type 1 viral spikes produced by replacement of the native trimerization domain with a heterologous trimerization motif: characterization and ligand binding analysis.

Marie Pancera, Jacob Lebowitz, Arne Schön, Ping Zhu, Ernesto Freire, Peter D Kwong, Kenneth H Roux, Joseph Sodroski, Richard Wyatt

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Marie PanceraVaccine Research Center, NIH, Bethesda, Bethesda, MD 20892, USA.
Jacob Lebowitz
Arne Schön
Ping Zhu
Ernesto Freire
Peter D Kwong
Kenneth H Roux
Joseph Sodroski
Richard Wyatt
Florida State University · USJohns Hopkins University · USDana-Farber Cancer Institute · US

Funding

Design Of ImmunogensZIAAI005024 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI ZHOU, TONGQING · 2009 to 2025
$21.5M
Design Of ImmunogensZ01AI005024 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI KWONG, PETER D · 2002 to 2008
$564k
Immmunogenicity and Structure of trimeric HIV-1 gp120 glycoproteinsZIAAI005068 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI WYATT, RICHARD THOMAS · 2009 to 2009
$540k
Immunogenicity and Structure of HIV-1 gp140 glycoproteiZ01AI005069 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI WYATT, RICHARD THOMAS · 2004 to 2008
$309k
Biophysics /Structure /Immunogenicity of HIV-1GlycoproteZ01AI005078 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI WYATT, RICHARD THOMAS · 2005 to 2008
$309k
Immmunogenicity and Structure of trimeric HIV-1 gp120 glycoproteinsZ01AI005068 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI WYATT, RICHARD THOMAS · 2004 to 2008
$194k
Biophysics, Structure and Immunogenicity of Stabilized HIV-1 Env glycoproteinsZIAAI005078 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI WYATT, RICHARD THOMAS · 2009 to 2009
$170k
Immmunogenicity and Structure of HIV-1 gp140 glycoproteinsZIAAI005069 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI WYATT, RICHARD THOMAS · 2009 to 2009
$170k
Characterizing Viral Protein Interactions and Other ProtZ01OD011081 · OD · OFFICE OF THE DIRECTOR, NIH · PI LEBOWITZ, JACOB · 2003 to 2006
–
6 · The paper itself

Abstract

The human immunodeficiency virus type 1 (HIV-1) exterior envelope glycoprotein, gp120, mediates binding to the viral receptors and, along with the transmembrane glycoprotein gp41, is a major target for neutralizing antibodies. We asked whether replacing the gp41 fusion/trimerization domain with a stable trimerization motif might lead to a more stable gp120 trimer that would be amenable to structural and immunologic analysis. To obtain stable gp120 trimers, a heterologous trimerization motif, GCN4, was appended to the C terminus of YU2gp120. Biochemical analysis indicated that the gp120-GCN4 trimers were superior to gp140 molecules in their initial homogeneity, and trilobed structures were observable by electron microscopy. Biophysical analysis of gp120-GCN4 trimers by isothermal titration calorimetry (ITC) and ultracentrifugation analyses indicated that most likely two molecules of soluble CD4 could bind to one gp120-GCN4 trimer. To further examine restricted CD4 stoichiometric binding to the gp120-GCN4 trimers, we generated a low-affinity CD4 binding trimer by introducing a D457V change in the CD4 binding site of each gp120 monomeric subunit. The mutant trimers could definitively bind only one soluble CD4 molecule, as determined by ITC and sedimentation equilibrium centrifugation. These data indicate that there are weak interactions between the gp120 monomeric subunits of the GCN4-stabilized trimers that can be detected by low-affinity ligand sensing. By similar analysis, we also determined that removal of the variable loops V1, V2, and V3 in the context of the gp120-GCN4 proteins allowed the binding of three CD4 molecules per trimer. Interestingly, both the gp120-GCN4 variants displayed a restricted stoichiometry for the CD4-induced antibody 17b of one antibody molecule binding per trimer. This restriction was not evident upon removal of the variable loops V1 and V2 loops, consistent with conformational constraints in the wild-type gp120 trimers and similar to those inherent in the functional Env spike. Thus, the gp120-GCN4 trimers demonstrate several properties that are consistent with some of those anticipated for gp120 in the context of the viral spike.

Indexed as

Amino Acid MotifsAnimalsBiomimeticsCD4 AntigensCell LineHIV-1HIV Envelope Protein gp120LigandsModels, MolecularProtein BindingStructure-Activity RelationshipCD4 AntigensHIV Envelope Protein gp120Ligands

Identifiers

PMID16014956
PMCPMC1181572
OpenAlexW2110679986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.